(Q41265231)

28 September 2017

Resistance to isosorbide dinitrate in patients with severe chronic heart failure: Incidence and attempt at hemodynamic prediction (English)

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Cardiology and cardiovascular medicine

9 January 2023

main subject

chronic heart failure

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

9 January 2023

author name string

D. Kulick

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3417975

9 January 2023

A. Roth

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3417975

9 January 2023

N. McIntosh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3417975

9 January 2023

S. H. Rahimtoola

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3417975

9 January 2023

U. Elkayam

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3417975

9 January 2023

language of work or name

English

0 references

publication date

1 October 1988

1 reference

full work available at URL

28 September 2017

https://api.elsevier.com/content/article/PII:0735109788904718?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

https://api.elsevier.com/content/article/PII:0735109788904718?httpAccept=text/plain

9 January 2023

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Journal of the American College of Cardiology

9 January 2023

published in

1 reference

28 September 2017

12

1 reference

28 September 2017

4

1 reference

28 September 2017

1023-1028

1 reference

Glyceryl trinitrate (nitroglycerin) ointment and isosorbide dinitrate: a review of their pharmacological properties and therapeutic use.

28 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Nitrate Therapy for Congestive Heart Failure

9 January 2023

2

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure

9 January 2023

3

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: Prolonged effectiveness of isosorbide dinitrate

9 January 2023

4

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure

9 January 2023

5

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure

9 January 2023

6

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Ineffectiveness of sublingual nitroglycerin in acute left ventricular failure in the presence of massive peripheral edema

9 January 2023

7

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure.

9 January 2023

8

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Hemodynamic and hormonal effects of high-dose transdermal nitroglycerin in patients with chronic congestive heart failure.

9 January 2023

9

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Pharmacokinetic-hemodynamic studies of intravenous nitroglycerin in congestive cardiac failure.

9 January 2023

10

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Sustained beneficial hemodynamic responses to large doses of transdermal nitroglycerin in congestive heart failure and comparison with intravenous nitroglycerin

9 January 2023

11

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure.

9 January 2023

12

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Cardiac output by thermodilution technique. Effect of injectate's volume and temperature on accuracy and reproducibility in the critically Ill patient

9 January 2023

13

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Acute hemodynamic effect of oral nifedipine in severe chronic congestive heart failure.

9 January 2023

14

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

GLC determination of nitroglycerin and isosorbide dinitrate in human plasma

9 January 2023

15

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure.

9 January 2023

16

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure.

9 January 2023

17

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Improvement in supine bicycle exercise performance in refractory congestive heart failure after isosorbide dinitrate: Radionuclide and hemodynamic evaluation of acute effects

9 January 2023

18

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

9 January 2023

19

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure

9 January 2023

20

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris

9 January 2023

21

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy

9 January 2023

22

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Dose requirements of hydralazine in patients with severe chronic congestive heart failure

9 January 2023

24

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates

9 January 2023

27

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine

9 January 2023

28

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate

9 January 2023

30

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Tolerance to isosorbide dinitrate: rate of development and reversal

9 January 2023

31

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

Nitrate tolerance: influence of isosorbide dinitrate on the hemodynamic and antianginal effects of nitroglycerin

9 January 2023

32

1 reference

https://api.crossref.org/works/10.1016/0735-1097(88)90471-8

9 January 2023

Identifiers

1 reference

28 September 2017

1 reference